Special Issue "Gene Therapy Used in Cancer Treatment"
A special issue of Biomedicines (ISSN 2227-9059).
Deadline for manuscript submissions: closed (15 March 2014)
Dr. Vincenzo Cerullo (Website)
1 ImmunoViroTherapy Lab (IVTLab), Helsinki, Finland
2 Centre for Drug Research (CDR) and Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
Interests: gene therapy; cancer gene therapy; immunotherapy; immunity; innate immunity; immunovirotherapy; oncolytic viruses; adenovirus; vaccinia virus
This special issue "Gene Therapy for Cancer Treatment" will be mainly focused on the different aspects of cancer gene therapy, gene immunotherapy and immunovirotherapy.
For long time the term "Cancer Gene Therapy" has been mostly referred to oncolytic viruses or viral vector expressing anti-tumor molecules, leaving aside immunotherapy approaches. Nowadays several studies have highlighted the capacity of viral and non-viral approaches to "turn-on" the immune system and the use of this feature to further potentiate the efficacy of the treatment.
More specifically, in this issue papers can be focused on viral and non-viral approaches to cancer therapy, their use as immunotherapy platforms, their modification to increase the safety and/or immunogenicity. Both preclinical and clinical studies will be considered.
Dr. Vincenzo Cerullo
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed Open Access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. For the first couple of issues the Article Processing Charge (APC) will be waived for well-prepared manuscripts. English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- gene therapy
- cancer gene therapy
- oncolytic viruses
- cancer vaccines